
Dr. Bjorkman has been a faculty member with CalTech for the past 35 years, currently serving as the David Baltimore Professor of Biology and Biological Engineering and as a Merkin Institute Professor. Throughout her career, she has conducted extensive research on HIV, coronaviruses, protein design, antibody therapeutics, and structural immunology. Her lab’s present focus is on immune recognition of viral pathogens. They have recently researched the SARS-CoV-2 virus to develop improved therapeutics and vaccines.
Dr. Bjorkman holds a bachelor’s degree from the University of Oregon and a Ph.D. from Harvard University.


